rs74882337

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_005763.4(AASS):​c.1678C>T​(p.Pro560Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00606 in 1,613,710 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0045 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0062 ( 37 hom. )

Consequence

AASS
NM_005763.4 missense

Scores

2
8
9

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts U:1B:6

Conservation

PhyloP100: 7.69

Publications

8 publications found
Variant links:
Genes affected
AASS (HGNC:17366): (aminoadipate-semialdehyde synthase) This gene encodes a bifunctional enzyme that catalyzes the first two steps in the mammalian lysine degradation pathway. The N-terminal and the C-terminal portions of this enzyme contain lysine-ketoglutarate reductase and saccharopine dehydrogenase activity, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde. Mutations in this gene are associated with familial hyperlysinemia. [provided by RefSeq, Jul 2008]
AASS Gene-Disease associations (from GenCC):
  • hyperlysinemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 7-122093136-G-A is Benign according to our data. Variant chr7-122093136-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 377290.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00449 (683/152236) while in subpopulation NFE AF = 0.00785 (534/68022). AF 95% confidence interval is 0.0073. There are 3 homozygotes in GnomAd4. There are 312 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AASSNM_005763.4 linkc.1678C>T p.Pro560Ser missense_variant Exon 16 of 24 ENST00000417368.7 NP_005754.2 Q9UDR5A4D0W4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AASSENST00000417368.7 linkc.1678C>T p.Pro560Ser missense_variant Exon 16 of 24 1 NM_005763.4 ENSP00000403768.2 Q9UDR5

Frequencies

GnomAD3 genomes
AF:
0.00449
AC:
683
AN:
152118
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00111
Gnomad AMI
AF:
0.0461
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00750
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00198
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00785
Gnomad OTH
AF:
0.00334
GnomAD2 exomes
AF:
0.00384
AC:
964
AN:
250956
AF XY:
0.00364
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.000261
Gnomad ASJ exome
AF:
0.00814
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00268
Gnomad NFE exome
AF:
0.00690
Gnomad OTH exome
AF:
0.00262
GnomAD4 exome
AF:
0.00623
AC:
9098
AN:
1461474
Hom.:
37
Cov.:
32
AF XY:
0.00599
AC XY:
4355
AN XY:
727060
show subpopulations
African (AFR)
AF:
0.000956
AC:
32
AN:
33462
American (AMR)
AF:
0.000291
AC:
13
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.00792
AC:
207
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
0.00316
AC:
169
AN:
53412
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5764
European-Non Finnish (NFE)
AF:
0.00759
AC:
8434
AN:
1111704
Other (OTH)
AF:
0.00396
AC:
239
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
460
920
1381
1841
2301
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
308
616
924
1232
1540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00449
AC:
683
AN:
152236
Hom.:
3
Cov.:
32
AF XY:
0.00419
AC XY:
312
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.00111
AC:
46
AN:
41538
American (AMR)
AF:
0.000392
AC:
6
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00750
AC:
26
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00198
AC:
21
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00785
AC:
534
AN:
68022
Other (OTH)
AF:
0.00331
AC:
7
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
36
72
109
145
181
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00650
Hom.:
23
Bravo
AF:
0.00448
TwinsUK
AF:
0.00647
AC:
24
ALSPAC
AF:
0.00701
AC:
27
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00779
AC:
67
ExAC
AF:
0.00390
AC:
473
EpiCase
AF:
0.00562
EpiControl
AF:
0.00557

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:4
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

AASS: BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 08, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

AASS-related disorder Benign:1
May 09, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Hyperlysinemia Benign:1
Oct 20, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Uncertain
-0.080
CADD
Pathogenic
34
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.46
T;T
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.75
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.96
.;D
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.010
T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Uncertain
2.2
M;M
PhyloP100
7.7
PrimateAI
Uncertain
0.52
T
PROVEAN
Uncertain
-3.3
D;D
REVEL
Benign
0.22
Sift
Benign
0.74
T;T
Sift4G
Benign
0.44
T;T
Polyphen
0.95
P;P
Vest4
0.68
MVP
0.72
MPC
0.63
ClinPred
0.026
T
GERP RS
6.0
Varity_R
0.26
gMVP
0.78
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.29
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.29
Position offset: -15

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74882337; hg19: chr7-121733190; API